PharmAust Ltd
PharmAust Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases in Switzerland, Australia, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials… Read more
PharmAust Ltd (PAA) - Total Liabilities
Latest total liabilities as of June 2024: AU$896.61K AUD
Based on the latest financial reports, PharmAust Ltd (PAA) has total liabilities worth AU$896.61K AUD as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PharmAust Ltd - Total Liabilities Trend (2001–2024)
This chart illustrates how PharmAust Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PharmAust Ltd Competitors by Total Liabilities
The table below lists competitors of PharmAust Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Singular Genomics Systems Inc
NASDAQ:OMIC
|
USA | $63.30 Million |
|
Fortune Rise Acquisition Corp
NASDAQ:FRLA
|
USA | $11.37 Million |
|
Capital & Regional Plc
PINK:CRPLF
|
USA | $253.90 Million |
|
Arctic Fish Holding AS
OL:AFISH
|
Norway | Nkr182.46 Million |
|
Optomed PLC
HE:OPTOMED
|
Finland | €6.95 Million |
|
The Cato Corporation
F:CO2A
|
Germany | €282.59 Million |
|
Korea New Network Co. Ltd
KQ:058400
|
Korea | ₩13.88 Billion |
|
TRJNF
PINK:TRJNF
|
USA | $90.01 Million |
Liability Composition Analysis (2001–2024)
This chart breaks down PharmAust Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 12.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.09 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PharmAust Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PharmAust Ltd (2001–2024)
The table below shows the annual total liabilities of PharmAust Ltd from 2001 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | AU$896.61K | -59.99% |
| 2023-06-30 | AU$2.24 Million | +0.33% |
| 2022-06-30 | AU$2.23 Million | +7.75% |
| 2021-06-30 | AU$2.07 Million | -6.62% |
| 2020-06-30 | AU$2.22 Million | +94.77% |
| 2019-06-30 | AU$1.14 Million | -6.55% |
| 2018-06-30 | AU$1.22 Million | -4.72% |
| 2017-06-30 | AU$1.28 Million | +3.73% |
| 2016-06-30 | AU$1.23 Million | +80.64% |
| 2015-06-30 | AU$683.22K | +68.29% |
| 2014-06-30 | AU$405.98K | -31.72% |
| 2013-06-30 | AU$594.54K | -50.28% |
| 2012-06-30 | AU$1.20 Million | +294.76% |
| 2011-06-30 | AU$302.95K | -70.31% |
| 2010-06-30 | AU$1.02 Million | -40.45% |
| 2009-06-30 | AU$1.71 Million | -17.55% |
| 2008-06-30 | AU$2.08 Million | -10.91% |
| 2007-06-30 | AU$2.33 Million | +57.28% |
| 2006-06-30 | AU$1.48 Million | +5.47% |
| 2005-06-30 | AU$1.41 Million | +758.20% |
| 2004-06-30 | AU$163.86K | -76.54% |
| 2003-06-30 | AU$698.49K | -52.03% |
| 2002-06-30 | AU$1.46 Million | +48.60% |
| 2001-06-30 | AU$979.80K | -- |